JP Stock MarketDetailed Quotes

4884 Kringle Pharma

Watchlist
  • 1044
  • +76+7.85%
20min DelayNot Open Jan 9 15:30 JST
7.11BMarket Cap-8.83P/E (Static)

Kringle Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
15.58%80.04M
43.27%24.34M
7.63%18.69M
-82.33%69.25M
-93.67%17.72M
17.18M
16.99M
17.37M
391.83M
279.76M
Cost of revenue
88.41M
Gross profit
15.58%80.04M
43.27%24.34M
7.63%18.69M
-77.18%69.25M
-90.74%17.72M
17.18M
16.99M
17.37M
303.42M
191.35M
Operating expense
-6.27%897.92M
27.54%222.49M
7.12%187.28M
31.31%958.01M
22.01%286M
322.73M
174.46M
174.83M
729.58M
234.41M
Operating profit
7.98%-817.88M
-25.84%-198.15M
-7.07%-168.59M
-108.55%-888.76M
-523.05%-268.27M
-305.55M
-157.47M
-157.47M
-426.17M
-43.06M
Net non-operating interest income (expenses)
102.61%189K
11.47%-7.24M
-7.33M
0
-8.18M
0
Non-operating interest income
114.77%189K
----
----
-57.49%88K
--0
--0
----
----
--207K
--0
Total other finance cost
----
----
----
-12.60%7.33M
----
----
----
----
--8.39M
--0
Net investment income
143.88%717K
2,969.64%1.61M
-11,722.22%-1.06M
-98.66%294K
-97.22%456K
-97K
-56K
-9K
21.92M
16.39M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
44.05%62.01M
0
544K
-47.55%43.05M
0
42.95M
82.08M
2.05M
Income before tax
11.46%-754.96M
-24.80%-196.36M
-7.39%-169.11M
-158.12%-852.66M
-1,017.67%-275.15M
-262.7M
-157.34M
-157.48M
-330.34M
-24.62M
Income tax
0.07%1.49M
0.27%374K
0.00%372K
0.00%1.49M
-0.27%372K
373K
373K
372K
1.49M
373K
Net income
11.44%-756.45M
-24.74%-196.73M
-7.37%-169.49M
-157.41%-854.15M
-1,002.48%-275.52M
-263.07M
-157.71M
-157.85M
-331.83M
-24.99M
Net income continuous operations
11.44%-756.45M
-24.74%-196.73M
-7.37%-169.49M
-157.41%-854.15M
-1,002.47%-275.52M
---263.08M
---157.71M
---157.85M
---331.83M
---24.99M
Noncontrolling interests
Net income attributable to the company
11.44%-756.45M
-24.74%-196.73M
-7.37%-169.49M
-157.41%-854.15M
-1,002.48%-275.52M
-263.07M
-157.71M
-157.85M
-331.83M
-24.99M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
11.44%-756.45M
-24.74%-196.73M
-7.37%-169.49M
-157.41%-854.15M
-1,002.48%-275.52M
-263.07M
-157.71M
-157.85M
-331.83M
-24.99M
Gross dividend payment
Basic earnings per share
25.40%-118.21
-4.75%-30.68
-0.65%-29.53
-131.90%-158.46
-1,441.09%-51.01
-48.82
-29.29
-29.34
-68.33
-3.31
Diluted earnings per share
25.40%-118.21
-4.75%-30.68
-0.65%-29.53
-131.90%-158.46
-998.26%-51.01
-48.82
-29.29
-29.34
-68.33
-4.6446
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Sep 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 15.58%80.04M43.27%24.34M7.63%18.69M-82.33%69.25M-93.67%17.72M17.18M16.99M17.37M391.83M279.76M
Cost of revenue 88.41M
Gross profit 15.58%80.04M43.27%24.34M7.63%18.69M-77.18%69.25M-90.74%17.72M17.18M16.99M17.37M303.42M191.35M
Operating expense -6.27%897.92M27.54%222.49M7.12%187.28M31.31%958.01M22.01%286M322.73M174.46M174.83M729.58M234.41M
Operating profit 7.98%-817.88M-25.84%-198.15M-7.07%-168.59M-108.55%-888.76M-523.05%-268.27M-305.55M-157.47M-157.47M-426.17M-43.06M
Net non-operating interest income (expenses) 102.61%189K11.47%-7.24M-7.33M0-8.18M0
Non-operating interest income 114.77%189K---------57.49%88K--0--0----------207K--0
Total other finance cost -------------12.60%7.33M------------------8.39M--0
Net investment income 143.88%717K2,969.64%1.61M-11,722.22%-1.06M-98.66%294K-97.22%456K-97K-56K-9K21.92M16.39M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 44.05%62.01M0544K-47.55%43.05M042.95M82.08M2.05M
Income before tax 11.46%-754.96M-24.80%-196.36M-7.39%-169.11M-158.12%-852.66M-1,017.67%-275.15M-262.7M-157.34M-157.48M-330.34M-24.62M
Income tax 0.07%1.49M0.27%374K0.00%372K0.00%1.49M-0.27%372K373K373K372K1.49M373K
Net income 11.44%-756.45M-24.74%-196.73M-7.37%-169.49M-157.41%-854.15M-1,002.48%-275.52M-263.07M-157.71M-157.85M-331.83M-24.99M
Net income continuous operations 11.44%-756.45M-24.74%-196.73M-7.37%-169.49M-157.41%-854.15M-1,002.47%-275.52M---263.08M---157.71M---157.85M---331.83M---24.99M
Noncontrolling interests
Net income attributable to the company 11.44%-756.45M-24.74%-196.73M-7.37%-169.49M-157.41%-854.15M-1,002.48%-275.52M-263.07M-157.71M-157.85M-331.83M-24.99M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 11.44%-756.45M-24.74%-196.73M-7.37%-169.49M-157.41%-854.15M-1,002.48%-275.52M-263.07M-157.71M-157.85M-331.83M-24.99M
Gross dividend payment
Basic earnings per share 25.40%-118.21-4.75%-30.68-0.65%-29.53-131.90%-158.46-1,441.09%-51.01-48.82-29.29-29.34-68.33-3.31
Diluted earnings per share 25.40%-118.21-4.75%-30.68-0.65%-29.53-131.90%-158.46-998.26%-51.01-48.82-29.29-29.34-68.33-4.6446
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP